|
related topics |
{property, intellectual, protect} |
{customer, product, revenue} |
{product, market, service} |
{product, liability, claim} |
{operation, international, foreign} |
{control, financial, internal} |
{cost, regulation, environmental} |
{personnel, key, retain} |
{regulation, government, change} |
{cost, operation, labor} |
{capital, credit, financial} |
|
We depend on private label sales arrangements and third party distributors for a significant portion of our revenues, the loss of one or more of which could reduce our future sales revenue
We may not succeed in establishing a separate brand identity for our Rochester Medical brand products
Our products may not succeed in the market
We face significant competition in the market for urinary continence products
Our products may become obsolete if we are unable to anticipate and adapt to new treatments or techniques
We have a limited history of profitability and may experience future losses
Our products and manufacturing activities are subject to extensive governmental regulation that could prevent us from selling our products or introducing new and/or improved products in the United States or internationally
Our success may depend on the ability of healthcare providers to achieve adequate levels of reimbursement from third-party payors, and cost containment measures could decrease the demand for our products and the prices that our customers are willing to pay for those products
Our business, financial condition, results of operations and cash flows could be significantly and adversely affected by recent healthcare reform legislation and other administration and legislative proposals.
We depend on certain key personnel, the loss of whom could harm our business
We depend on a few suppliers for key components, making us vulnerable to supply shortages and price fluctuation
All of our manufacturing operations are conducted at a single industrial park; therefore, any disruption at our existing facilities could substantially affect our business
We depend on patents and proprietary rights, which we may not be able to protect
We may face intellectual property infringement claims that would be costly to resolve
We may face product liability claims that could result in costly litigation and significant liabilities
Our operations are subject to environmental, health and safety laws and regulations that could require us to incur material costs.
Our international sales and operations expose us to foreign currency fluctuations and additional risks and uncertainties that could adversely affect our results of operations
Weakness in the United States and international economies may continue to adversely affect our business
Our strategic business plan may not produce the intended growth in revenue and operating income.
We may be unable to meet our future capital requirements
Full 10-K form ▸
|
|
related documents |
868368--12/11/2009--ROCHESTER_MEDICAL_CORPORATION |
868368--12/26/2006--ROCHESTER_MEDICAL_CORPORATION |
868368--12/4/2007--ROCHESTER_MEDICAL_CORPORATION |
868368--12/12/2008--ROCHESTER_MEDICAL_CORPORATION |
225263--3/14/2007--NEWPORT_CORP |
225263--3/16/2006--NEWPORT_CORP |
313927--2/24/2009--CHURCH_&_DWIGHT_CO_INC_/DE/ |
313927--2/24/2010--CHURCH_&_DWIGHT_CO_INC_/DE/ |
771252--3/8/2007--DIGITAL_ANGEL_CORP |
225263--3/11/2008--NEWPORT_CORP |
797448--4/2/2007--VERSO_TECHNOLOGIES_INC |
1013606--2/29/2008--ENDOLOGIX_INC_/DE/ |
313927--2/27/2008--CHURCH_&_DWIGHT_CO_INC_/DE/ |
1013606--3/16/2006--ENDOLOGIX_INC_/DE/ |
22252--5/1/2009--COMARCO_INC |
1324759--3/31/2010--Cereplast_Inc |
712515--5/30/2007--ELECTRONIC_ARTS_INC |
1014507--6/1/2006--SCHICK_TECHNOLOGIES_INC |
70793--12/11/2006--NBTY_INC |
1033905--2/25/2010--LUMINEX_CORP |
1033905--2/26/2009--LUMINEX_CORP |
1173489--3/14/2008--CEVA__INC |
851205--2/11/2010--COGNEX_CORP |
70793--11/27/2007--NBTY_INC |
790818--3/18/2010--X_RITE_INC |
1173489--3/16/2007--CEVA__INC |
1013606--3/12/2007--ENDOLOGIX_INC_/DE/ |
851205--2/17/2009--COGNEX_CORP |
18937--2/26/2008--CERADYNE_INC |
353569--2/26/2010--QUIDEL_CORP_/DE/ |
|